Bone Biologics CorporationBBLG
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · bonebiologics.com
Bone Biologics is a clinical-stage medical device and biologics company developing NELL-1/DBX, an osteoinductive bone graft product candidate for spinal fusion procedures.
Key ratios
ROA
-33.5%TTM
2025
-41.9%2024
-69.4%2023
-96.3%
ROE
-55.0%TTM
2025
-70.2%2024
-128.7%2023
-202.2%
Track BBLG in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer